Swander Pace Capital Appoints New CEO to Lead Captek Softgel International, Inc.

CERRITOS, Calif.--(BUSINESS WIRE)--Swander Pace Capital (“SPC”), an experienced private equity firm specializing in investing in consumer staples, announced today the next generation of leadership at Captek Softgel International (“Captek”), an SPC portfolio company. Brett Buatti has been appointed CEO of Captek effective immediately. Captek is an established Vitamin, Mineral & Supplement (“VMS”) soft gel and gummy manufacturer in North America.

Brett brings more than 20 years of senior management experience in a broad range of consumer products categories to this position. He previously served as Chief Operations & Supply Chain Officer at Aspire Bakeries and held various leadership roles at best-in-class publicly traded and privately held companies including The Bountiful Company and Pharmative in the health and wellness space.

“I am thrilled to lead such a talented organization,” said Mr. Buatti. “Captek has tremendous people and capabilities, and I am eager to take the business to the next level.”

“We are pleased to have the capability and expertise of Brett Buatti at Captek,” said Corby Reese, Chairman of the Board at Captek and Senior Advisor at Swander Pace Capital. “Captek is entering a new chapter, and we are delighted to see this highly differentiated and strategically important asset continue to thrive under Brett’s leadership.”

“The people at Captek are making a difference every day, and we are excited for Brett to accelerate that impact,” said Alex Litt, Managing Director at Swander Pace Capital. “Captek enjoys a unique and innovative position in the marketplace, and we are confident the addition of Brett as CEO will help further drive our success.”

About Captek Softgel International, Inc.
Captek Softgel International, Inc. (CSI) is a privately-owned, FDA registered and audited, GMP-certified, full-service contract manufacturer of custom dietary supplement formulations. CSI features high efficiency encapsulation lines operating 24/5, capable of producing more than 10 billion soft gels annually. Their facilities encompass approximately 295,000 square feet of production, analytical laboratory, pilot laboratory, and warehousing space. Captek fully complies with FDA cGMP’s and has been independently certified by NSF International. For more information, visit www.capteksoftgel.com.

About Swander Pace Capital
Swander Pace Capital (SPC) is a private equity firm that invests in companies that are integral to consumers’ lives. SPC’s consumer industry experience informs the firm’s strategic approach and seeks to add value through access to its SPC Playbook, senior team, and extensive network. The firm partners with management teams to help build companies to their full potential. SPC invests in businesses across two key domains of consumer lifestyles: Food and Beverage and Health and Wellness. With offices in California and New Jersey, SPC has invested in approximately 65 platform companies and raised cumulative equity commitments of approximately $2.2 billion since 1996. For more information, visit www.spcap.com.